Primiano Christopher Brett
Related Filers (2)
Ownership (37)
4
Friday, 10/29/2021
Aura Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/28/2021
Aura Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/3/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/4/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/14/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/10/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/11/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/21/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/19/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/7/2020
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/31/2019
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/10/2019
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/19/2019
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/11/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/10/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/6/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/8/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/25/2018
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/9/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/6/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/18/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/1/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/30/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2017
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2016
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/8/2016
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2016
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/9/2015
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/21/2015
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/22/2015
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/13/2014
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/17/2014
Karyopharm Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/25/2014
Karyopharm Therapeutics Inc.: Initial statement of beneficial ownership of securities